Restructuring and Other Costs (Tables)

9 Months Ended

Oct. 02, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs [Table Text Block]

During the third quarter of 2021, the company recorded net restructuring and other costs (income) by segment as follows:

(In millions)	Cost of Revenues		Selling, General and Administrative Expenses		Restructuring and Other Costs		Total
Life Sciences Solutions	$	—	$	23	$	(3)	$	20
Analytical Instruments	—		1		2		3
Specialty Diagnostics	—		—		14		14
Laboratory Products and Services	—		26		(3)		23
Corporate	—		9		8		17
	$	—	$	59	$	18	$	77

During the first nine months of 2021, the company recorded net restructuring and other costs (income) by segment as follows:

(In millions)	Cost of Revenues		Selling, General and Administrative Expenses		Restructuring and Other Costs		Total
Life Sciences Solutions	$	8	$	(24)	$	125	$	109
Analytical Instruments	—		1		5		6
Specialty Diagnostics	—		(2)		17		15
Laboratory Products and Services	—		49		(5)		44
Corporate	—		9		9		18
	$	8	$	33	$	151	$	192

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

The following table summarizes the changes in the company’s accrued restructuring balance. Other amounts reported as restructuring and other costs in the accompanying statement of income have been summarized in the notes to the table. Accrued restructuring costs are included in other accrued expenses in the accompanying balance sheet.

(In millions)	Total (a)
Balance at December 31, 2020	21
Net restructuring charges incurred in 2021 (b)	23
Payments	(31)
Currency translation	(1)
Balance at October 2, 2021	$	12

(a)The movements in the restructuring liability principally consist of severance and other costs such as relocation and moving expenses associated with facility consolidations, as well as employee retention costs which are accrued ratably over the period through which employees must work to qualify for a payment.

(b)Excludes $128 million of net charges, principally for impairment of acquired technology, compensation contractually due and paid to employees of acquired businesses at the date of acquisition, fixed asset write-downs, and charges associated with pre-acquisition related matters.